Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
102,089,423
-
Total 13F shares
-
85,449,652
-
Share change
-
-868,685
-
Total reported value
-
$602,397,711
-
Put/Call ratio
-
141%
-
Price per share
-
$7.05
-
Number of holders
-
169
-
Value change
-
-$3,593,270
-
Number of buys
-
83
-
Number of sells
-
95
Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q3 2025
As of 30 Sep 2025,
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,449,652 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P., FRANKLIN RESOURCES INC, Rubric Capital Management LP, STATE STREET CORP, Vestal Point Capital, LP, and Pictet Asset Management Holding SA.
This page lists
169
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.